{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T22:00:59Z","timestamp":1753740059983},"reference-count":28,"publisher":"Pharmaceutical Society of Japan","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological & Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2017]]},"DOI":"10.1248\/bpb.b16-00733","type":"journal-article","created":{"date-parts":[[2017,1,31]],"date-time":"2017-01-31T22:21:59Z","timestamp":1485901319000},"page":"195-204","source":"Crossref","is-referenced-by-count":5,"title":["Identification of Adenovirus-Derived Cell-Penetrating Peptide"],"prefix":"10.1248","volume":"40","author":[{"given":"Takamasa","family":"Hirai","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics and Biopharmaceutics, Showa Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Yamagishi","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics and Biopharmaceutics, Showa Pharmaceutical University"},{"name":"Division of Clinical Virology, Graduate School of Medicine, Kobe University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Koizumi","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics and Biopharmaceutics, Showa Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miwa","family":"Nonaka","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics and Biopharmaceutics, Showa Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rina","family":"Mochida","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics and Biopharmaceutics, Showa Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenta","family":"Shida","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics and Biopharmaceutics, Showa Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Nomura","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics and Biopharmaceutics, Showa Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makiko","family":"Fujii","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics and Biopharmaceutics, Showa Pharmaceutical University"},{"name":"Laboratory of Physical Chemistry, School of Pharmacy, Nihon University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuminori","family":"Sakurai","sequence":"additional","affiliation":[{"name":"Laboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Mizuguchi","sequence":"additional","affiliation":[{"name":"Laboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka University"},{"name":"iPS Cell-Based Research Project on Hepatic Toxicity and Metabolism, Graduate School of Pharmaceutical Sciences, Osaka University"},{"name":"Global Center for Advanced Medical Engineering and Informatics, Osaka University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiteru","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics and Biopharmaceutics, Showa Pharmaceutical University"},{"name":"Department of Pharmacy, Tohoku Medical and Pharmaceutical University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Utoguchi","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics and Biopharmaceutics, Showa Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS, Horwitz MS, Crowell RL, Finberg RW. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science<\/i>, 275<\/b>, 1320\u20131323 (1997).","DOI":"10.1126\/science.275.5304.1320"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Tomko RP, Xu R, Philipson L. HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc. Natl. Acad. Sci. U.S.A.<\/i>, 94<\/b>, 3352\u20133356 (1997).","DOI":"10.1073\/pnas.94.7.3352"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Wickham TJ, Mathias P, Cheresh DA, Nemerow GR. Integrins \u03b1v\u03b23 and \u03b1v\u03b25 promote adenovirus internalization but not virus attachment. Cell<\/i>, 73<\/b>, 309\u2013319 (1993).","DOI":"10.1016\/0092-8674(93)90231-E"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Wickham TJ, Filardo EJ, Cheresh DA, Nemerow GR. Integrin av\u00df5 selectively promotes adenovirus mediated cell membrane permeabilization. J. Cell Biol.<\/i>, 127<\/b>, 257\u2013264 (1994).","DOI":"10.1083\/jcb.127.1.257"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Nakamura T, Sato K, Hamada H. Reduction of natural adenovirus tropism to the liver by both ablation of fiber-coxsackievirus and adenovirus receptor interaction and use of replaceable short fiber. J. Virol.<\/i>, 77<\/b>, 2512\u20132521 (2003).","DOI":"10.1128\/JVI.77.4.2512-2521.2003"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Smith TA, Idamakanti N, Marshall-Neff J, Rollence ML, Wright P, Kaloss M, King L, Mech C, Dinges L, Iverson WO, Sherer AD, Markovits JE, Lyons RM, Kaleko M, Stevenson SC. Receptor interactions involved in adenoviral-mediated gene delivery after systemic administration in non-human primates. Hum. Gene Ther.<\/i>, 14<\/b>, 1595\u20131604 (2003).","DOI":"10.1089\/104303403322542248"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Smith TA, Idamakanti N, Rollence ML, Marshall-Neff J, Kim J, Mulgrew K, Nemerow GR, Kaleko M, Stevenson SC. Adenovirus serotype 5 fiber shaft influences in vivo<\/i> gene transfer in mice. Hum. Gene Ther.<\/i>, 14<\/b>, 777\u2013787 (2003).","DOI":"10.1089\/104303403765255165"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Murakami S, Sakurai F, Kawabata K, Okada N, Fujita T, Yamamoto A, Hayakawa T, Mizuguchi H. Interaction of penton base Arg-Gly-Asp motifs with integrins is crucial for adenovirus serotype 35 vector transduction in human hematopoietic cells. Gene Ther.<\/i>, 14<\/b>, 1525\u20131533 (2007).","DOI":"10.1038\/sj.gt.3303019"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Trotman LC, Achermann DP, Keller S, Straub M, Greber UF. Non-classical export of an adenovirus structural protein. Traffic<\/i>, 4<\/b>, 390\u2013402 (2003).","DOI":"10.1034\/j.1600-0854.2003.00094.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Akita H, Ito R, Khalil IA, Futaki S, Harashima H. Quantitative three-dimensional analysis of the intracellular trafficking of plasmid DNA transfected by a nonviral gene delivery system using confocal laser scanning microscopy. Mol. Ther.<\/i>, 9<\/b>, 443\u2013451 (2004).","DOI":"10.1016\/j.ymthe.2004.01.005"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Hama S, Akita H, Ito R, Mizuguchi H, Hayakawa T, Harashima H. Quantitative comparison of intracellular trafficking and nuclear transcription between adenoviral and lipoplex systems. Mol. Ther.<\/i>, 13<\/b>, 786\u2013794 (2006).","DOI":"10.1016\/j.ymthe.2005.10.007"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Amstutz B, Gastaldelli M, K\u00e4lin S, Imelli N, Boucke K, Wandeler E, Mercer J, Hemmi S, Greber UF. Subversion of CtBP1-controlled macropinocytosis by human adenovirus serotype 3. EMBO J.<\/i>, 27<\/b>, 956\u2013969 (2008).","DOI":"10.1038\/emboj.2008.38"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) K\u00e4lin S, Amstutz B, Gastaldelli M, Wolfrum N, Boucke K, Havenga M, DiGennaro F, Liska N, Hemmi S, Greber UF. Macropinocytotic uptake and infection of human epithelial cells with species B2 adenovirus type 35. J. Virol.<\/i>, 84<\/b>, 5336\u20135350 (2010).","DOI":"10.1128\/JVI.02494-09"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Meier O, Boucke K, Hammer SV, Keller S, Stidwill RP, Hemmi S, Greber UF. Adenovirus triggers macropinocytosis and endosomal leakage together with its clathrin-mediated uptake. J. Cell Biol.<\/i>, 158<\/b>, 1119\u20131131 (2002).","DOI":"10.1083\/jcb.200112067"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Zhang D, Wang J, Xu D. Cell-penetrating peptides as noninvasive transmembrane vectors for the development of novel multifunctional drug-delivery systems. J. Control. Release<\/i>, 229<\/b>, 130\u2013139 (2016).","DOI":"10.1016\/j.jconrel.2016.03.020"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Frankel AD, Pabo CO. Cellular uptake of the tat protein from human immunodeficiency virus. Cell<\/i>, 55<\/b>, 1189\u20131193 (1988).","DOI":"10.1016\/0092-8674(88)90263-2"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Mizuguchi H, Koizumi N, Hosono T, Ishii-Watabe A, Uchida E, Utoguchi N, Watanabe Y, Hayakawa T. CAR- or alpha v integrin-binding ablated adenovirus vectors, but not fiber-modified vectors containing RGD peptide, do not change the systemic gene transfer properties in mice. Gene Ther.<\/i>, 9<\/b>, 769\u2013776 (2002).","DOI":"10.1038\/sj.gt.3301701"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Koizumi N, Mizuguchi H, Sakurai F, Yamaguchi T, Watanabe Y, Hayakawa T. Reduction of natural adenovirus tropism to mouse liver by fiber-shaft exchange in combination with both CAR- and alpha v integrin-binding ablation. J. Virol.<\/i>, 77<\/b>, 13062\u201313072 (2003).","DOI":"10.1128\/JVI.77.24.13062-13072.2003"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Koizumi N, Kawabata K, Sakurai F, Watanabe Y, Hayakawa T, Mizuguchi H. Modified adenoviral vectors ablated for coxsackievirus-adenovirus receptor, alpha v integrin, and heparan sulfate binding reduce in vivo<\/i> tissue transduction and toxicity. Hum. Gene Ther.<\/i>, 17<\/b>, 264\u2013279 (2006).","DOI":"10.1089\/hum.2006.17.264"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Maizel JV Jr, White DO, Scharff MD. The polypeptides of adenovirus: I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12. Virology<\/i>, 36<\/b>, 115\u2013125 (1968).","DOI":"10.1016\/0042-6822(68)90121-9"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Mizuguchi H, Kay MA. Efficient construction of a recombinant adenovirus vector by an improved in vitro<\/i> ligation method. Hum. Gene Ther.<\/i>, 9<\/b>, 2577\u20132583 (1998).","DOI":"10.1089\/hum.1998.9.17-2577"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Meier O, Greber UF. Adenovirus endocytosis. J. Gene Med.<\/i>, 5<\/b>, 451\u2013462 (2003).","DOI":"10.1002\/jgm.409"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Elliott G, O\u2019Hare P. Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell<\/i>, 88<\/b>, 223\u2013233 (1997).","DOI":"10.1016\/S0092-8674(00)81843-7"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Skotland T, Iversen TG, Torgersen ML, Sandvig K. Cell-penetrating peptides: possibilities and challenges for drug delivery in vitro<\/i> and in vivo<\/i>. Molecules<\/i>, 20<\/b>, 13313\u201313323 (2015).","DOI":"10.3390\/molecules200713313"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Cascales L, Henriques ST, Kerr MC, Huang YH, Sweet MJ, Daly NL, Craik DJ. Identification and characterization of a new family of cell-penetrating peptides: cyclic cell-penetrating peptides. J. Biol. Chem.<\/i>, 286<\/b>, 36932\u201336943 (2011).","DOI":"10.1074\/jbc.M111.264424"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Kanazawa T, Morisaki K, Suzuki S, Takashima Y. Prolongation of life in rats with malignant glioma by intranasal siRNA\/drug codelivery to the brain with cell-penetrating peptide-modified micelles. Mol. Pharm.<\/i>, 11<\/b>, 1471\u20131478 (2014).","DOI":"10.1021\/mp400644e"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Khafagy el-S, Morishita M. Oral biodrug delivery using cell-penetrating peptide. Adv. Drug Deliv. Rev.<\/i>, 64<\/b>, 531\u2013539 (2012).","DOI":"10.1016\/j.addr.2011.12.014"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Hsu T, Mitragotri S. Delivery of siRNA and other macromolecules into skin and cells using a peptide enhancer. Proc. Natl. Acad. Sci. U.S.A.<\/i>, 108<\/b>, 15816\u201315821 (2011).","DOI":"10.1073\/pnas.1016152108"}],"container-title":["Biological & Pharmaceutical Bulletin","Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/40\/2\/40_b16-00733\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T09:27:56Z","timestamp":1498382876000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/40\/2\/40_b16-00733\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b16-00733","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}